181 related articles for article (PubMed ID: 22527247)
1. Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma.
Jia H; Li Y; Zhao T; Li X; Hu J; Yin D; Guo B; Kopecko DJ; Zhao X; Zhang L; Xu DQ
Cancer Immunol Immunother; 2012 Nov; 61(11):1977-87. PubMed ID: 22527247
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.
Tian Y; Guo B; Jia H; Ji K; Sun Y; Li Y; Zhao T; Gao L; Meng Y; Kalvakolanu DV; Kopecko DJ; Zhao X; Zhang L; Xu D
Cancer Gene Ther; 2012 Jun; 19(6):393-401. PubMed ID: 22555509
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
[TBL] [Abstract][Full Text] [Related]
4. Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment.
Li X; Li Y; Wang B; Ji K; Liang Z; Guo B; Hu J; Yin D; Du Y; Kopecko DJ; Kalvakolanu DV; Zhao X; Xu D; Zhang L
J Cancer Res Clin Oncol; 2013 Jun; 139(6):971-80. PubMed ID: 23463096
[TBL] [Abstract][Full Text] [Related]
5. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling.
Kong D; Chen J; Sun X; Lin Y; Du Y; Huang D; Cheng H; He P; Yang L; Wu S; Zhao L; Meng X
Biosci Trends; 2019; 13(4):342-350. PubMed ID: 31527330
[TBL] [Abstract][Full Text] [Related]
6. Combined endostatin and TRAIL gene transfer suppresses human hepatocellular carcinoma growth and angiogenesis in nude mice.
Zhang Y; Qu ZH; Cui M; Guo C; Zhang XM; Ma CH; Sun WS
Cancer Biol Ther; 2009 Mar; 8(5):466-73. PubMed ID: 19223770
[TBL] [Abstract][Full Text] [Related]
7. YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.
Kong J; Kong F; Gao J; Zhang Q; Dong S; Gu F; Ke S; Pan B; Shen Q; Sun H; Zheng L; Sun W
Mol Cancer; 2014 Jan; 13():7. PubMed ID: 24418169
[TBL] [Abstract][Full Text] [Related]
8. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z
Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
Mohan CD; Bharathkumar H; Bulusu KC; Pandey V; Rangappa S; Fuchs JE; Shanmugam MK; Dai X; Li F; Deivasigamani A; Hui KM; Kumar AP; Lobie PE; Bender A; Basappa ; Sethi G; Rangappa KS
J Biol Chem; 2014 Dec; 289(49):34296-307. PubMed ID: 25320076
[TBL] [Abstract][Full Text] [Related]
11. Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy.
Wang XH; Liu BR; Qu B; Xing H; Gao SL; Yin JM; Wang XF; Cheng YQ
Neoplasma; 2011; 58(2):158-71. PubMed ID: 21275467
[TBL] [Abstract][Full Text] [Related]
12. [Gene transfection of endostatin synergizes with doxorubicin to suppress human hepatocellular carcinomas: experiment with mice].
Liu FJ; Tan G; Li J; Sun XY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2147-51. PubMed ID: 19080480
[TBL] [Abstract][Full Text] [Related]
13. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
Zuo M; Li C; Lin J; Javle M
Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
[TBL] [Abstract][Full Text] [Related]
14. Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery.
Li L; Huang JL; Liu QC; Wu PH; Liu RY; Zeng YX; Huang WL
World J Gastroenterol; 2004 Jul; 10(13):1867-71. PubMed ID: 15222025
[TBL] [Abstract][Full Text] [Related]
15. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
16. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
17. Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
Liu JY; Chiang T; Liu CH; Chern GG; Lin TT; Gao DY; Chen Y
Mol Ther; 2015 Nov; 23(11):1772-1782. PubMed ID: 26278330
[TBL] [Abstract][Full Text] [Related]
18. 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis.
Kornek M; Lukacs-Kornek V; Limmer A; Raskopf E; Becker U; Klöckner M; Sauerbruch T; Schmitz V
Mol Med; 2008; 14(7-8):365-73. PubMed ID: 18392108
[TBL] [Abstract][Full Text] [Related]
19. Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice.
Schmitz V; Wang L; Barajas M; Gomar C; Prieto J; Qian C
Gut; 2004 Apr; 53(4):561-7. PubMed ID: 15016752
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
